PROTEASOME INHIBITOR, BORTEZOMIB, OVERCOMES RESISTANCE TO TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) IN TREATMENT-REFRACTORY MALIGNANT HUMAN GLIOMA CELLS

被引:0
|
作者
Kang, Peter [1 ]
Jane, Esther P. [1 ]
Premkumar, Daniel R. [1 ]
Pollack, Ian F. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
下载
收藏
页码:93 / 93
页数:1
相关论文
共 50 条
  • [21] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reduces dengue viral load in human infected cells
    Warke, Rajas
    Martin, Kathy
    Giaya, Kris
    Becerra-Artiles, Aniuska
    Bosch, Norma
    Rothman, Alan
    Bosch, Irene
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 231 - 231
  • [22] Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis
    Nguyen, T
    Zhang, XD
    Hersey, P
    CLINICAL CANCER RESEARCH, 2001, 7 (03) : 966S - 973S
  • [23] The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells
    Feng, Xiaoli
    Yan, Jie
    Wang, Yibiao
    Zierath, Juleen R.
    Nordenskjold, Magnus
    Henter, Jan-Inge
    Fadeel, Bengt
    Zheng, Chengyun
    MOLECULAR IMMUNOLOGY, 2010, 47 (14) : 2388 - 2396
  • [24] Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
    Elmallah, Mohammed I. Y.
    Micheau, Olivier
    MARINE DRUGS, 2015, 13 (11) : 6884 - 6909
  • [25] Roles of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in experimental autoimmune encephalomyelitis
    Hilliard, B
    Wilmen, A
    Seidel, C
    Liu, TT
    Göke, R
    Chen, Y
    FASEB JOURNAL, 2000, 14 (06): : A1101 - A1101
  • [26] Roles of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in experimental autoimmune encephalomyelitis
    Chen, YH
    Hilliard, BA
    Wilmen, A
    FASEB JOURNAL, 2001, 15 (05): : A1210 - A1210
  • [27] Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis
    Schoppet, M
    Sattler, AM
    Schaefer, JR
    Hofbauer, LC
    ATHEROSCLEROSIS, 2006, 184 (02) : 446 - 447
  • [28] Viral transfer of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in gene therapy
    Wedrowska, Ewelina
    Wandtke, Tomasz
    Dyczek, Andrzej
    Wozniak, Joanna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2015, 69 : 1411 - 1422
  • [29] The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand
    Horinaka, M
    Yoshida, T
    Shiraishi, T
    Nakata, S
    Wakada, M
    Sakai, T
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (04) : 945 - 951
  • [30] Novel Molecular Regulators of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis in NSCLC Cells
    Ge, Yang
    Yan, Dong
    Deng, Haiteng
    Chen, Wenming
    An, Guangyu
    CLINICAL LABORATORY, 2015, 61 (12) : 1855 - 1863